Acarix
0.29 SEK
+1.79 %
Less than 1K followers
ACARIX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Acarix
EV/S
Median 2019-2021
EV/EBIT
Median 2019-2021
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 0.86 | 0.91 | 0.72 | 0.26 | 0.19 | 0.25 | 0.27 |
| Shares | 37.8 | 106.5 | 170.5 | 279.1 | 475.1 | 920.8 | 1,164.7 |
| Market cap | 32.4 | 96.6 | 123.0 | 71.8 | 90.2 | 231.1 | 312.1 |
| Enterprise value | -20.6 | 33.8 | 107.7 | - | - | - | - |
| EV/S | neg. | 15.6 | 28.6 | - | - | - | - |
| EV/EBITDA | 0.5 | neg. | neg. | - | - | - | - |
| EV/EBIT | 0.4 | neg. | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 0.42 | 1.18 | 1.22 | 1.39 | 1.74 | 3.05 | 8.18 |
| P/S | 17.4 | 44.5 | 32.7 | 12.3 | 14.5 | 37.3 | 42.4 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 92.3 % | 91.3 % | 84.8 % | 74.6 % | 82.5 % | 93.7 % | 79.0 % |
| Gearing ratio | 1.0 % | 1.7 % | 0.5 % | 0.5 % | - | - | - |